Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
22 pending office actions • 15 art units • 22 examiners • 0 of 22 (0%) have an AI response strategy ready • 19 patents granted in the last 365 days
The University of Connecticut currently has 24 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are handled by 24 distinct examiners, meaning that each pending matter is assigned to a different individual. This distribution shows that the company's prosecution experience is entirely decentralized across its active cases, with no examiner overlap currently present in the data.
The portfolio spans 17 distinct art units, indicating a high degree of technical variety within the biotechnology and pharmaceutical fields. The busiest examiner, TADESSE, YEWEBDAR T, is responsible for 1 pending office action. This confirms that even the most active examiner handles only a single case, as the total workload is spread across many individuals.
Practitioners must navigate the specific requirements of 17 distinct art units, which likely have different examination standards. Because 24 distinct examiners are involved in the 24 pending office actions, there is no opportunity to apply insights from a single examiner to multiple cases. The various art units represent the broad technical landscape the University of Connecticut is currently navigating.
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (14%) |
| §103 only | 5 (23%) |
| §112 only | 2 (9%) |
| Double-patenting + other | 1 (5%) |
| Multi-statute (no §101) | 11 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TADESSE, YEWEBDAR T | 1 | 81.4% | +19.2% |
| TRUONG, CAM Y T | 1 | 82.3% | +61.4% |
| STEPHENS, JACQUELINE F | 1 | 75.6% | +14.8% |
| SIRCAR, ALISHA JITENDRA | 1 | 58.1% | +58.1% |
| TIWARI, VYOMA SHUBHAM | 1 | 31.5% | +48.1% |
| ALLEN, SARAH ELIZABETH | 1 | 57.1% | +50.0% |
| CESARE, JOSEPH DAVID | 1 | — | — |
| MAHLUM, JONATHAN DAVIS | 1 | 51.4% | +25.6% |
| CRAIGO, WILLIAM A | 1 | 49.2% | +38.2% |
| ROGERS, JAMES WILLIAM | 1 | 46.2% | +22.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18658442 | DERIVATION OF ELECTRODERMAL ACTIVITY RESPONSE FROM AN ELECTROCARDIOGRAM SIGNAL | SIRCAR, ALISHA JITENDRA | 23d overdue |
| 18352185 | THERAPEUTIC BANDAGE | KASHYAP, ESHA PRAKASH | 15d overdue |
| 18449499 | DEVICES FOR FORMING IN SITU MICRONEEDLES AND METHODS THEREOF | MEDWAY, SCOTT J | 27d |
| 18248021 | NANOMATERIAL AND METHODS OF USE THEREOF | BECKHARDT, LYNDSEY MARIE | 56d |
| 19196295 | Record Linkage and Entity Resolution | TRUONG, CAM Y T | 70d |
| 19213690 | Electrospinning Apparatus and Uses Thereof | TADESSE, YEWEBDAR T | — |
| 18658102 | DISSOLUTION ADAPTER, METHOD OF MANUFACTURE THEREOF AND METHOD OF USE THEREOF | STEPHENS, JACQUELINE F | — |
| 18652048 | PORCINE MUSCLE EXTRACELLULAR MATRIX-DERIVED HYDROGEL AND USES THEREOF | TIWARI, VYOMA SHUBHAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18658442 | DERIVATION OF ELECTRODERMAL ACTIVITY RESPONSE FROM AN ELECTROCARDIOGRAM SIGNAL | SIRCAR, ALISHA JITENDRA | 23d overdue |
| 19196295 | Record Linkage and Entity Resolution | TRUONG, CAM Y T | 70d |
| 19213690 | Electrospinning Apparatus and Uses Thereof | TADESSE, YEWEBDAR T | — |
| 18658102 | DISSOLUTION ADAPTER, METHOD OF MANUFACTURE THEREOF AND METHOD OF USE THEREOF | STEPHENS, JACQUELINE F | — |
| 18652048 | PORCINE MUSCLE EXTRACELLULAR MATRIX-DERIVED HYDROGEL AND USES THEREOF | TIWARI, VYOMA SHUBHAM | — |
| 18630651 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF GLYCOGEN STORAGE DISORDERS | ALLEN, SARAH ELIZABETH | — |
| 18438074 | Transcription Factor GLI1 Inhibitors and Uses Thereof | MAHLUM, JONATHAN DAVIS | — |
| 18535288 | PHOTO-CROSSLINKABLE PLANT-BASED MATERIALS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME | CRAIGO, WILLIAM A | — |
| Art Unit | Apps |
|---|---|
| 3783 | 3 |
| 1613 | 2 |
| 1718 | 1 |
| 2169 | 1 |
| 3781 | 1 |
| 3792 | 1 |
| 1625 | 1 |
| 1615 | 1 |
| 1618 | 1 |
| 1677 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19213690 | Electrospinning Apparatus and Uses Thereof | TADESSE, YEWEBDAR T | 1718 | §102§103 | Non-Final OA | — | Pending | May 20, 2025 |
| 19196295 | Record Linkage and Entity Resolution | TRUONG, CAM Y T | 2169 | §101§103§112 | Non-Final OA | 70d | Pending | May 01, 2025 |
| 18658102 | DISSOLUTION ADAPTER, METHOD OF MANUFACTURE THEREOF AND METHOD OF USE THEREOF | STEPHENS, JACQUELINE F | 3781 | §102§103§112 | Non-Final OA | — | Pending | May 08, 2024 |
| 18658442 | DERIVATION OF ELECTRODERMAL ACTIVITY RESPONSE FROM AN ELECTROCARDIOGRAM SIGNAL | SIRCAR, ALISHA JITENDRA | 3792 | §101§103 | Final Rejection | 23d overdue | Pending | May 08, 2024 |
| 18652048 | PORCINE MUSCLE EXTRACELLULAR MATRIX-DERIVED HYDROGEL AND USES THEREOF | TIWARI, VYOMA SHUBHAM | — | §103§112 | Non-Final OA | — | Pending | May 01, 2024 |
| 18630651 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF GLYCOGEN STORAGE DISORDERS | ALLEN, SARAH ELIZABETH | — | §112 | Non-Final OA | — | Pending | Apr 09, 2024 |
| 18685958 | NON-OPIOID METHODS FOR TREATING PAIN | CESARE, JOSEPH DAVID | — | §102§103§112 | Non-Final OA | — | Pending | Feb 23, 2024 |
| 18438074 | Transcription Factor GLI1 Inhibitors and Uses Thereof | MAHLUM, JONATHAN DAVIS | 1625 | §102§103§112 | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18535288 | PHOTO-CROSSLINKABLE PLANT-BASED MATERIALS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME | CRAIGO, WILLIAM A | 1615 | §102§103§112DP | Final Rejection | — | Pending | Dec 11, 2023 |
| 18491536 | INHIBITORS OF CYTOCHROME P450 FAMILY 7 SUBFAMILY B MEMBER 1 (CYP7B1) FOR USE IN MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS | ROGERS, JAMES WILLIAM | 1618 | §102§103 | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18449499 | DEVICES FOR FORMING IN SITU MICRONEEDLES AND METHODS THEREOF | MEDWAY, SCOTT J | 3783 | §103§112 | Final Rejection | 27d | Pending | Aug 14, 2023 |
| 18262443 | SYNTHETIC ARTIFICIAL STEM CELLS (SASC) | KIM, DANIELLE A | 1613 | §103 | Final Rejection | 61d | Pending | Jul 21, 2023 |
| 18352185 | THERAPEUTIC BANDAGE | KASHYAP, ESHA PRAKASH | 3783 | §102§103 | Final Rejection | 15d overdue | Pending | Jul 13, 2023 |
| 18351317 | ULTRASENSITIVE SENSING METHOD FOR DETECTION OF BIOMOLECULES | EVANS, CHRISTOPHER RYAN | 1677 | §102§103§112 | Non-Final OA | — | Pending | Jul 12, 2023 |
| 18270368 | Use of Fibroblast Growth Factor-8 For Tissue Regeneration | NGUYEN, NGHI V | 1653 | §103 | Non-Final OA | — | Pending | Jun 29, 2023 |
| 18250114 | NANOPARTICLES FOR IMAGING AND THERAPY | BASQUILL, SEAN M | 1614 | §103 | Non-Final OA | — | Pending | Apr 21, 2023 |
| 18248021 | NANOMATERIAL AND METHODS OF USE THEREOF | BECKHARDT, LYNDSEY MARIE | 1613 | §102§103Other | Final Rejection | 56d | Pending | Apr 05, 2023 |
| 18027384 | IMPLANTABLE MEDICAL DEVICES WITH ENHANCED BIOCOMPATIBILITY | PRICE, NATHAN R | 3783 | §103§112 | Non-Final OA | — | Pending | Mar 21, 2023 |
| 18041811 | NANODRUGS FOR TARGETED DRUG DELIVERY AND USE THEREOF | RONEY, CELESTE A | 1612 | §103 | Non-Final OA | 16d | Pending | Feb 16, 2023 |
| 18017551 | BIOMEDICAL BIG DATA ANALYSIS PROGRAM | PLAYER, ROBERT AUSTIN | — | §101§103§112 | Non-Final OA | — | Pending | Jan 23, 2023 |
| 18006235 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS | ANGELL, JON E | 1637 | §112 | Non-Final OA | — | Pending | Jan 20, 2023 |
| 17840869 | System and Method for Sensory Transmission Block by Electrical Stimulation of Neural Tissue | FEDORKY, MEGAN TAYLOR | 3796 | §103 | Final Rejection | — | Pending | Jun 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial